- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07308665
Aquacel With Strengthening Fiber (WSF) Ribbon Dressings
December 17, 2025 updated by: ConvaTec Inc.
A Multi-site Retrospective Study of the Real-world Performance of Aquacel With Strengthening Fiber (WSF) Ribbon Dressings
Retrospective, multi-site, non-comparative, post-market study
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Retrospective, multi-site, non-comparative, post-market study to evaluate real-world performance of Aquacel WSF Ribbon dressings in wound healing
Study Type
Observational
Enrollment (Actual)
214
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Patients who received an Aquacel WSF Ribbon dressing and who's data was collected in Wound Care Advantage (WCA).
Description
Inclusion Criteria:
- Subjects who have received one or more Aquacel WSF Ribbon dressing
Exclusion Criteria:
- Patients who have not received one or more Aquacel WSF Ribbon dressings
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Aquacel Ribbon
Aquacel WSF Ribbon treatment
|
Subjects who received an Aquacel WSF Ribbon
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Real-world efficacy of Aquacel WSF Ribbon in improving the incidence of wound closure
Time Frame: Baseline and week 4, 12, 20
|
Time to complete wound closure, defined as 100% epithelialization of the wound surface
|
Baseline and week 4, 12, 20
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wound size
Time Frame: Baseline and week 4, 12, 20
|
Measured size (area, volume) of target wound at each visit
|
Baseline and week 4, 12, 20
|
|
Wound dept
Time Frame: Baseline and week 4, 12, 20
|
Measured wound depth at each visit
|
Baseline and week 4, 12, 20
|
|
Exudate volume
Time Frame: Baseline and week 4, 12, 20
|
Changes in exudate volume
|
Baseline and week 4, 12, 20
|
|
Application use
Time Frame: Up to week 20
|
Number of Aquacel WSF Ribbon applications per subject over treatment course
|
Up to week 20
|
|
Visit frequency
Time Frame: Up to week 20
|
Number of visit frequency
|
Up to week 20
|
|
Dressing wear time
Time Frame: Baseline and week 4, 12, 20
|
Aquacel WSF Ribbon wear time
|
Baseline and week 4, 12, 20
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Christina Mastandrea, ConvaTec Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2017
Primary Completion (Actual)
April 8, 2025
Study Completion (Actual)
September 17, 2025
Study Registration Dates
First Submitted
December 17, 2025
First Submitted That Met QC Criteria
December 17, 2025
First Posted (Actual)
December 30, 2025
Study Record Updates
Last Update Posted (Actual)
December 30, 2025
Last Update Submitted That Met QC Criteria
December 17, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WC-24-450
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound Infection
-
Pulmatrix Inc.TerminatedPost Operative Wound Infection | Postoperative Wound Infection-deepUnited States
-
Brigham and Women's HospitalRecruitingWound Infection and Wound HealingUnited States
-
Carilion ClinicSmith & Nephew, Inc.; DeRoyal Industries, Inc.CompletedImpaired Wound Healing | Postoperative Wound Infection-deepUnited States
-
PolyPid Ltd.CompletedPostoperative Wound Infection Superficial Incisional | Postoperative Wound Infection Deep Incisional Surgical SiteIsrael
-
Children's Healthcare of AtlantaWithdrawnPostoperative Wound InfectionUnited States
-
Military Medical AcademyRecruitingPostoperative Wound Infection Superficial Incisional | Postoperative Wound Infection Deep Incisional Surgical SiteBulgaria
-
Prof. Dr. Bülent M. ErtuğrulBaşakşehir Çam & Sakura City HospitalActive, not recruitingIdentification | Wound Infection BacterialTurkey (Türkiye)
-
PfizerCompletedSurgical Wound Infection | Postoperative Wound Infection
-
HITEC-Institute of Medical SciencesCompletedWound Infection | Wound Dehiscence | Wound Surgical | Wound BleedingPakistan
-
Universitat Internacional de CatalunyaHospital de GranollersCompletedSurgical Wound Infection | Postoperative Wound Infection | Postoperative Wound Infection Superficial Incisional | Preventive TherapySpain
Clinical Trials on Aquacel Ribbon
-
ABIGO Medical ABNot yet recruitingHard-to-heal Wounds | Diabetic Foot Ulcer | Venous Leg Ulcer | Pressure Ulcer | Arterial Leg Ulcer
-
Medacta International SARecruitingAnterior Cruciate Ligament (ACL) ReconstructionAustria, Germany
-
IWK Health CentreActive, not recruiting
-
ConvaTec Inc.CompletedLeg UlcerUnited Kingdom, Germany, Netherlands, Poland
-
Golden Jubilee National HospitalConvaTec Inc.Withdrawn
-
ConvaTec Inc.Bristol-Myers SquibbCompletedSplit-Thickness Donor Sites.United States
-
National Taiwan University HospitalUnknownUlcer | Head and Neck Cancer | Head and Neck Neoplasms | WoundsTaiwan
-
Valleywise HealthCompletedAbscess | CellulitisUnited States
-
Columbia UniversityKinetic Concepts, Inc.CompletedWound ComplicationUnited States, Canada
-
Cairo UniversityCompleted